Olmesartan Medoxomil in Hypertension and Renal Impairment
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
This is a study in hypertensive patients with mild to moderate renal impairment. The
antihypertensive efficacy of olmesartan medoxomil is compared to losartan.